Report Detail

Request for Sample of this report

Other Global Drugs for Osteoarthritis Pain Market 2025 by Company, Regions, Type and Application, Forecast to 2031

  • RnM4656434
    • |
  • 05 December, 2025
    • |
  • Global
    • |
  • 124 Pages
    • |
  • GIR
    • |
  • Other

According to our (Global Info Research) latest study, the global Drugs for Osteoarthritis Pain market size was valued at US$ 10650 million in 2024 and is forecast to a readjusted size of USD 15700 million by 2031 with a CAGR of 5.8% during review period.
Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.
North America is the largest Drugs for Osteoarthritis Pain market with about 36% market share. Europe is follower, accounting for about 27% market share.
The key players are Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma etc. Top 5 companies occupied about 66% market share.
This report is a detailed and comprehensive analysis for global Drugs for Osteoarthritis Pain market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Drugs for Osteoarthritis Pain market size and forecasts, in consumption value ($ Million), 2020-2031
Global Drugs for Osteoarthritis Pain market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Drugs for Osteoarthritis Pain market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Drugs for Osteoarthritis Pain market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Drugs for Osteoarthritis Pain
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Drugs for Osteoarthritis Pain market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Drugs for Osteoarthritis Pain market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oral
Injection
External
Market segment by Application
Medical Care
Personal Care
Market segment by players, this report covers
Pfizer
Johnson & Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Drugs for Osteoarthritis Pain product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Drugs for Osteoarthritis Pain, with revenue, gross margin, and global market share of Drugs for Osteoarthritis Pain from 2020 to 2025.
Chapter 3, the Drugs for Osteoarthritis Pain competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Drugs for Osteoarthritis Pain market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drugs for Osteoarthritis Pain.
Chapter 13, to describe Drugs for Osteoarthritis Pain research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Drugs for Osteoarthritis Pain by Type
    • 1.3.1 Overview: Global Drugs for Osteoarthritis Pain Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Drugs for Osteoarthritis Pain Consumption Value Market Share by Type in 2024
    • 1.3.3 Oral
    • 1.3.4 Injection
    • 1.3.5 External
  • 1.4 Global Drugs for Osteoarthritis Pain Market by Application
    • 1.4.1 Overview: Global Drugs for Osteoarthritis Pain Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Medical Care
    • 1.4.3 Personal Care
  • 1.5 Global Drugs for Osteoarthritis Pain Market Size & Forecast
  • 1.6 Global Drugs for Osteoarthritis Pain Market Size and Forecast by Region
    • 1.6.1 Global Drugs for Osteoarthritis Pain Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Drugs for Osteoarthritis Pain Market Size by Region, (2020-2031)
    • 1.6.3 North America Drugs for Osteoarthritis Pain Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Drugs for Osteoarthritis Pain Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Drugs for Osteoarthritis Pain Market Size and Prospect (2020-2031)
    • 1.6.6 South America Drugs for Osteoarthritis Pain Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Drugs for Osteoarthritis Pain Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Drugs for Osteoarthritis Pain Product and Solutions
    • 2.1.4 Pfizer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Pfizer Recent Developments and Future Plans
  • 2.2 Johnson & Johnson
    • 2.2.1 Johnson & Johnson Details
    • 2.2.2 Johnson & Johnson Major Business
    • 2.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Product and Solutions
    • 2.2.4 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.3 GlaxoSmithKline
    • 2.3.1 GlaxoSmithKline Details
    • 2.3.2 GlaxoSmithKline Major Business
    • 2.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Product and Solutions
    • 2.3.4 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 GlaxoSmithKline Recent Developments and Future Plans
  • 2.4 Bayer
    • 2.4.1 Bayer Details
    • 2.4.2 Bayer Major Business
    • 2.4.3 Bayer Drugs for Osteoarthritis Pain Product and Solutions
    • 2.4.4 Bayer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Bayer Recent Developments and Future Plans
  • 2.5 Eli Lilly
    • 2.5.1 Eli Lilly Details
    • 2.5.2 Eli Lilly Major Business
    • 2.5.3 Eli Lilly Drugs for Osteoarthritis Pain Product and Solutions
    • 2.5.4 Eli Lilly Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Eli Lilly Recent Developments and Future Plans
  • 2.6 Novartis
    • 2.6.1 Novartis Details
    • 2.6.2 Novartis Major Business
    • 2.6.3 Novartis Drugs for Osteoarthritis Pain Product and Solutions
    • 2.6.4 Novartis Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Novartis Recent Developments and Future Plans
  • 2.7 Sanofi
    • 2.7.1 Sanofi Details
    • 2.7.2 Sanofi Major Business
    • 2.7.3 Sanofi Drugs for Osteoarthritis Pain Product and Solutions
    • 2.7.4 Sanofi Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Sanofi Recent Developments and Future Plans
  • 2.8 Horizon Pharma
    • 2.8.1 Horizon Pharma Details
    • 2.8.2 Horizon Pharma Major Business
    • 2.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Product and Solutions
    • 2.8.4 Horizon Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Horizon Pharma Recent Developments and Future Plans
  • 2.9 Abbott
    • 2.9.1 Abbott Details
    • 2.9.2 Abbott Major Business
    • 2.9.3 Abbott Drugs for Osteoarthritis Pain Product and Solutions
    • 2.9.4 Abbott Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Abbott Recent Developments and Future Plans
  • 2.10 Mylan
    • 2.10.1 Mylan Details
    • 2.10.2 Mylan Major Business
    • 2.10.3 Mylan Drugs for Osteoarthritis Pain Product and Solutions
    • 2.10.4 Mylan Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Mylan Recent Developments and Future Plans
  • 2.11 Daiichi Sankyo
    • 2.11.1 Daiichi Sankyo Details
    • 2.11.2 Daiichi Sankyo Major Business
    • 2.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Product and Solutions
    • 2.11.4 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Daiichi Sankyo Recent Developments and Future Plans
  • 2.12 TEVA
    • 2.12.1 TEVA Details
    • 2.12.2 TEVA Major Business
    • 2.12.3 TEVA Drugs for Osteoarthritis Pain Product and Solutions
    • 2.12.4 TEVA Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 TEVA Recent Developments and Future Plans
  • 2.13 Almatica Pharma
    • 2.13.1 Almatica Pharma Details
    • 2.13.2 Almatica Pharma Major Business
    • 2.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Product and Solutions
    • 2.13.4 Almatica Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Almatica Pharma Recent Developments and Future Plans
  • 2.14 Astellas Pharma
    • 2.14.1 Astellas Pharma Details
    • 2.14.2 Astellas Pharma Major Business
    • 2.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Product and Solutions
    • 2.14.4 Astellas Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Astellas Pharma Recent Developments and Future Plans
  • 2.15 Tide Pharmaceutical
    • 2.15.1 Tide Pharmaceutical Details
    • 2.15.2 Tide Pharmaceutical Major Business
    • 2.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Product and Solutions
    • 2.15.4 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Tide Pharmaceutical Recent Developments and Future Plans
  • 2.16 Iroko Pharmaceuticals
    • 2.16.1 Iroko Pharmaceuticals Details
    • 2.16.2 Iroko Pharmaceuticals Major Business
    • 2.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product and Solutions
    • 2.16.4 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Iroko Pharmaceuticals Recent Developments and Future Plans
  • 2.17 Hengrui Pharmaceutical
    • 2.17.1 Hengrui Pharmaceutical Details
    • 2.17.2 Hengrui Pharmaceutical Major Business
    • 2.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product and Solutions
    • 2.17.4 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 Hengrui Pharmaceutical Recent Developments and Future Plans
  • 2.18 Abiogen Pharma
    • 2.18.1 Abiogen Pharma Details
    • 2.18.2 Abiogen Pharma Major Business
    • 2.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Product and Solutions
    • 2.18.4 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2025)
    • 2.18.5 Abiogen Pharma Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Drugs for Osteoarthritis Pain Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Drugs for Osteoarthritis Pain by Company Revenue
    • 3.2.2 Top 3 Drugs for Osteoarthritis Pain Players Market Share in 2024
    • 3.2.3 Top 6 Drugs for Osteoarthritis Pain Players Market Share in 2024
  • 3.3 Drugs for Osteoarthritis Pain Market: Overall Company Footprint Analysis
    • 3.3.1 Drugs for Osteoarthritis Pain Market: Region Footprint
    • 3.3.2 Drugs for Osteoarthritis Pain Market: Company Product Type Footprint
    • 3.3.3 Drugs for Osteoarthritis Pain Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Drugs for Osteoarthritis Pain Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Drugs for Osteoarthritis Pain Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Drugs for Osteoarthritis Pain Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Drugs for Osteoarthritis Pain Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Drugs for Osteoarthritis Pain Consumption Value by Type (2020-2031)
  • 6.2 North America Drugs for Osteoarthritis Pain Market Size by Application (2020-2031)
  • 6.3 North America Drugs for Osteoarthritis Pain Market Size by Country
    • 6.3.1 North America Drugs for Osteoarthritis Pain Consumption Value by Country (2020-2031)
    • 6.3.2 United States Drugs for Osteoarthritis Pain Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Drugs for Osteoarthritis Pain Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Drugs for Osteoarthritis Pain Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Drugs for Osteoarthritis Pain Consumption Value by Type (2020-2031)
  • 7.2 Europe Drugs for Osteoarthritis Pain Consumption Value by Application (2020-2031)
  • 7.3 Europe Drugs for Osteoarthritis Pain Market Size by Country
    • 7.3.1 Europe Drugs for Osteoarthritis Pain Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Drugs for Osteoarthritis Pain Market Size and Forecast (2020-2031)
    • 7.3.3 France Drugs for Osteoarthritis Pain Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Drugs for Osteoarthritis Pain Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Drugs for Osteoarthritis Pain Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Drugs for Osteoarthritis Pain Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Drugs for Osteoarthritis Pain Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Drugs for Osteoarthritis Pain Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Region
    • 8.3.1 Asia-Pacific Drugs for Osteoarthritis Pain Consumption Value by Region (2020-2031)
    • 8.3.2 China Drugs for Osteoarthritis Pain Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Drugs for Osteoarthritis Pain Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Drugs for Osteoarthritis Pain Market Size and Forecast (2020-2031)
    • 8.3.5 India Drugs for Osteoarthritis Pain Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Drugs for Osteoarthritis Pain Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Drugs for Osteoarthritis Pain Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Drugs for Osteoarthritis Pain Consumption Value by Type (2020-2031)
  • 9.2 South America Drugs for Osteoarthritis Pain Consumption Value by Application (2020-2031)
  • 9.3 South America Drugs for Osteoarthritis Pain Market Size by Country
    • 9.3.1 South America Drugs for Osteoarthritis Pain Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Drugs for Osteoarthritis Pain Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Drugs for Osteoarthritis Pain Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Drugs for Osteoarthritis Pain Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Drugs for Osteoarthritis Pain Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country
    • 10.3.1 Middle East & Africa Drugs for Osteoarthritis Pain Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Drugs for Osteoarthritis Pain Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Drugs for Osteoarthritis Pain Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Drugs for Osteoarthritis Pain Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Drugs for Osteoarthritis Pain Market Drivers
  • 11.2 Drugs for Osteoarthritis Pain Market Restraints
  • 11.3 Drugs for Osteoarthritis Pain Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Drugs for Osteoarthritis Pain Industry Chain
  • 12.2 Drugs for Osteoarthritis Pain Upstream Analysis
  • 12.3 Drugs for Osteoarthritis Pain Midstream Analysis
  • 12.4 Drugs for Osteoarthritis Pain Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Drugs for Osteoarthritis Pain. Industry analysis & Market Report on Drugs for Osteoarthritis Pain is a syndicated market report, published as Global Drugs for Osteoarthritis Pain Market 2025 by Company, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Drugs for Osteoarthritis Pain market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo